Sclerotherapy of idiopatic hydrocele with polidocanol: A study about 190 cases

##plugins.themes.academic_pro.article.sidebar##

Published May 6, 2011
Download
pdf
Vol. 89 No. 5 (2011): Issue May 2011

##plugins.themes.academic_pro.article.main##

Sataa Sallami
Mohamed Yassine Binous
Sami Ben Rhouma
Mohamed Chelif
Mohamed Hmidi
Yasssine Nouira
Nawfel Ben Rais
Ali Horchani

Abstract

Aim: To evaluate the efficacy and side-effects of Polidocanol used as sclerosing agent for testicular hydrocele.
Methods: One hundred and ninety men, with a median age of 55,9 years (40-89), treated for idiopatic hydrocele were assessed. After puncture and aspiration, the empty sac was instilled with 3% Polidocanol. We recorded recurrence, complications and associated pain on a visual analogue scale.
Results: With a median follow-up of 19 months, The cure rate of hydroceles after one sclerotherapy session was 62,1%, and the overall cure rate using the procedure was 82,6%. Re-instillation was done for recurrences in 41% of patients. Polidocanol therapy was almost pain-free. A low rate of complications was observed.
Conclusion: Polidocanol is a useful sclerosing agent for treating testicular hydrocele. Due to its ease of administration, low frequency of complications, high rate of effectiveness, and excellent tolerability; we recommend sclerotherapy with polidocanol as the primary treatment for hydroceles.

Keywords:

Hydrocele, Sclerotherapy, Polidocanol, Complication

##plugins.themes.academic_pro.article.details##

References

  1. Rowland RG, Danohue JP: Scrotum and testis, in Gillenwater JY, Grayhack JT, Howards SS, et al (Eds): Adult and Pediatric Urology. Chicago, Year Book Medical Publishers, 1987, vol 2, pp 1375-1376.
  2. Moloney G.E. Comparison of results of treatment of hydrocele and epididymal cysts by surgery and injection. Br Med J. 1975; 3: 478- 9.
  3. Daehlin L, Tønder B, Kapstad L. Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst. Br J Urol.1997; 80: 468-71.
  4. Sigurdsson T, Johansson JE, Jahnson S, Helgesen F, Andersson SO. Polidocanol sclerotherapy for hydroceles and epididymal cysts. J Urol. 1994; 151:898-901.
  5. Stattin P, Karlberg L, Damber JE. Long-term outcome of patients treated for hydrocele with the sclerosant agent sodium tetradecyl sulphate. Scand J Urol Nephrol. 1996; 30: 109-13.
  6. Tammela TL, Hellström PA, Mattila SI, Ottelin PJ, Malinen LJ, Mäkäräinen HP. Ethanolamine oleate sclerotherapy for hydroceles and spermatoceles: a survey of 158 patients with ultrasound followup. J Urol. 1992; 147: 1551-3.
  7. Savion M, Wolloch Y, Savir A. Phenol sclerotherapy for hydrocele: a study in 55 patients. J Urol. 1989; 142: 1500-1.
  8. Musa MT, Fahal AH, el Arabi YE. Aspiration sclerotherapy for hydroceles in the tropics. Br J Urol. 1995; 76: 488-90.
  9. Rencken RK, Bornman MS, Reif S, Olivier I. Sclerotherapy for hydroceles. J Urol. 1990; 143: 940-3.
  10. Bullock N, Thurston AV. Tetracycline sclerotherapy for hydroceles and epididymal cysts. Br J Urol. 1987; 59: 340-2.
  11. Merenciano Cortina FJ, Rafie Mazketli W, Amat Cecilia M, Romero Pérez P. Sclerotherapy of hydrocele and cord cyst with polidocanol. Efficiency study. Actas Urol Esp. 2001; 25: 704-9.
  12. Lund L, Bartolin J. Treatment of hydrocele testis with aspiration and injection of polidocanol. J Urol. 1992; 147: 1065-6.
  13. Fariña LA, Villavicencio H. Treatment of hydrocele with evacuation and percutaneous sclerosis with polidocanol. Actas Urol Esp. 1994; 18: 690-3.
  14. Fuse H, Sakamoto M, Fujishiro Y, Katayama T. Sclerotherapy of hydroceles with polidocanol. Int Urol Nephrol. 1994; 26: 199-204.
  15. Miskowiak J, Christensen AB. Treatment of hydrocele testis by injection of tetracycline. Eur Urol. 1988; 14: 440-1.
  16. Hu K-N, Khan AS, Gonder M. Sclerotherapy with tetracycline solution for hydrocele. Urology. 1984; 24: 572-5.
  17. Levine LA, Dewolf WC. Aspiration and tetracycline sclerotherapy of hydroceles. J Urol. 1988; 139: 959-60.
  18. Arslan M, Kilinç M, Yilmaz K, Oztürk A. A new approach in the management of the hydrocele with a silicone catheter. Urology. 2004; 63: 170-3.
  19. Macfarlane JR. Sclerosant therapy for hydroceles and epididymal cysts. Br J Urol. 1983; 55: 81-2.
  20. Ozkan S, Bircan K, Ozen H. Treatment of testicular hydrocele with tetracycline sclerotherapy. Int Urol Nephrol. 1990; 22: 67-9.
  21. Greene WR. "Window operation" for hydrocele. Urology. 1987; 30: 513.
  22. Beiko DT, Kim D, Morales A. Aspiration and sclerotherapy versus hydrocelectomy for treatment of hydroceles. Urology. 2003; 61: 708-12.
  23. Jahnson S, Johansson JE. Results of window operation for primary hydrocele. Urology. 1993; 41: 27-8.
  24. Yachia D. Window technique for hydrocele. Urology. 1986; 27: 576.
  25. Ku JH, Kim ME, Lee NK, Park YH. The excisional, plication and internal drainage techniques: a comparison of the results for idiopathic hydrocele. BJU Int. 2001; 87: 82-4.
  26. Fracchia JA, Armenakas NA, Kohan AD. Cost-effective hydrocele ablation. J Urol. 1998; 159: 864-7.
  27. Attyaoui F, Barrak A, Binous MY, Kbaier I, Horchani A. La chirurgie urologique ambulatoire. Tunis Med. 2000; 78: 254-9.
  28. Zimmerman RE, Nevin RS, Allen DJ, Jones CD, Goettel ME, Burck PJ. Antifertility effects of tetradecyl sodium sulphate in rabbits. J Reprod Fertil. 1983; 68: 257-63.
  29. Osegbe DN. Fertility after sclerotherapy for hydrocele. Lancet. 1991; 337:172.